Stay updated with breaking news from Van Deventer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A Vancouver-based health sciences company that was attempting to develop synthetic scorpion venom withheld relevant information from investors, but that omission did not necessarily have an impact on the company's stock price, B.C.'s financial regulator has ruled.
A BCSC hearing panel determined PreveCeutical Medical Inc. and CEO Stephen Van Deventer did not meet the threshold of making misrepresentations.
A BCSC hearing panel determined PreveCeutical Medical Inc. and CEO Stephen Van Deventer did not meet the threshold of making misrepresentations.
PreveCeutical Medical Inc. announces that the Company has missed the filing deadline of April 29, 2024 to file the Company's audited annual financial statements and accompanying management's...
Seventy cases of alleged financial crimes have been referred to the police for further investigation